Skip to main content

Biologic/Novel Rx

Panel Presentation: Psoriatic Arthritis

Drs. Eric Ruderman, Alexis Ogdie, Jessica Walsh, and Jose Scher discuss the giselkumab trials, where IL-23 inhibitors fit in practice, ixekizumab withdrawal, and more that presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Panel Presentation: Spondyloarthritis

Drs. Jack Cush, Christopher Ritchlin, Sophia Ramiro, Lianne Gensler, and Jessica Walsh discuss interesting new trials and data presented in ankylosing spondylitis and spondyloarthritis at the 2019 ACR/ARP annual meeting in Atlanta.  

Panel Presentation: Gout

Drs. Jack Cush, Nicola Dalbreth, Ken Saag and Robert Keenan discuss several gout presentations, including tart cherry, safety and efficacy of therapies, quality of life issues and more at the 2019 ACR/ARP annual meeting in Atlanta. 

Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau

Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

New Treatments for Axial Spondyloarthritis: Dr. Antoni Chan

Dr. Chan discusses several studies on spondyloarthritis presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Ixekizimab Withdrawal in PSA: Dr. Eric Ruderman

Dr. Ruderman highlights abstract #1532 at the 2019 ACR/ARP annual meeting in Atlanta.

TULIP Trials in Lupus: Dr. Mike Putman

Dr. Putman discusses abstracts # L17 and 1763 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Comparison of Ixekizumab and Adalimumab in PsA: Dr. Olga Petryna

Dr. Petryna discusses abstract #L20 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Overview of Several Gout Studies: Dr. Philip Robinson

Dr. Robinson highlights a number of gout-related abstracts, including #1236, #1217, #1218, #1235, at the ACR/ARP annual meeting in Atlanta. 

Subcutaneous Biosimilar: Dr. Jonathan Kay

Dr. Kay highlights abstract #548 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

MTX Withdraw after Starting JAK Inhibitors: Dr. Arthur Lau

Dr. Lau discusses abstract #1412 presented at the 2019 ACR/ARP Annual Meeting in Atlanta. 

Highlights of AS, Psoriatic Arthritis Studies: Dr. Lianne Gensler

Dr. Gensler reviews several studies on ankylosing spondylitis, non-radiographic axSpA, and psoriatic arthritis treatment presented at the 2019 ACR/ARP annual meeting in Atlanta. 

SELECT-MONOTHERAPY Trial: Dr. Mike Putman

Dr. Mike Putman discusses his takeaway from the SELECT-MONOTHERAPY trial at the 2019 ACR/ARP annual meeting in Atlanta. 

Clinical Infection Risk and Safety Profile in RA: Dr. Kathryn Dao

Dr. Dao summarizes a number of studies presented on infection risk and safety profile in RA at the 2019 ACR/ARP annual meeting in Atlanta. 

Upadacitinib in RA: Dr. Cassandra Calabrese

Dr. Calabrese discusses abstract #547 and abstract #509 as presented at the ACR/ARP annual meeting in Atlanta. 

MACE + VTE Across Multiple Upadacitinib Studies in RA: Dr. Jonathan Kay

Dr. Kay discusses abstract #846 presented at the ACR/ARP annual meeting in Atlanta. 

Biosimilars: Dr. Arthur Kavanaugh

Dr. Kavanaugh highlights two immunogenicity studies at the 2019 ACR/ARP annual meeting in Atlanta. 

×